Abbott grows cardiac portfolio with Amplatzer approval for valve leaks

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 29 Oct, 13:36 UTC

The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient from another open-heart surgery.

science

Sources

• T2Abbott grows cardiac portfolio with Amplatzer approval for valve leaksBioPharma Dive / Healthcare Dive / MedTech Dive29 Oct, 13:36